Annenberg Public Policy Center

Public knowledge varies greatly on flu and COVID-19

The latest Annenberg Public Health and Knowledge Survey finds the answers to eight survey questions—four for the flu and four for COVID—have the strongest ability to independently predict individual vaccine willingness.

From the Annenberg Public Policy Center



In the News


The Hill

Flu surges in the Southeast

A survey from the Annenberg Public Policy Center found that more than a third of people are concerned about either themselves or one of their family members contracting either the flu, COVID-19, or RSV.

FULL STORY →



Science

Correction is courageous

A study by Kathleen Hall Jamieson of the Annenberg Public Policy Center and colleagues suggests that public trust of a system for correcting errors in the scientific record would go a long way to building trust across ideologies.

FULL STORY →



Harrisburg Patriot-News

Vaccine trust plunges in U.S., with misinformation drowning out truth: survey

A survey by Kathleen Hall Jamieson of the Annenberg Public Policy Center and colleagues finds that American trust in vaccines has fallen significantly in just a few years, even with more fact-checking and pleas from doctors in response to viral misinformation.

FULL STORY →



Philadelphia Inquirer

Pandemic-era misinformation erodes confidence in all vaccines, Penn researchers find in new survey

A survey by Kathleen Hall Jamieson of the Annenberg Public Policy Center and colleagues finds that a steady flow of misinformation about COVID-19 and its vaccinations has weakened public confidence in long-established vaccines.

FULL STORY →



Axios

Jill Biden helps debut modern version of “Schoolhouse Rock”

A 2022 survey from the Annenberg Public Policy Center found that less than half of U.S. adults could name all three branches of government.

FULL STORY →



Stat

How headlines about the RSV antibody injection could cloud parents’ decision-making

In a co-written Op-Ed, Kathleen Hall Jamieson of the Annenberg Public Policy Center says that attention-grabbing headlines could conflate the new RSV antibody injection with anti-vaccine sentiment.

FULL STORY →